DISCLOSING OR NOT THE UNSOLICITED FINDINGS DURING A HIGH-THROUGHPUT SEQUENCING GENETIC TEST? AN EXAMPLE OF RESEARCH TO UNDERSTAND THE WEIGHT GIVEN TO CONSENT IN DECISION-MAKING

Authors

  • Myriam GUEDJ Myriam Guedj, CERPPS, Université Toulouse II Jean Jaurès
  • Marion ROSIER Marion Rosier, CERPPS, Université Toulouse II Jean Jaurès
  • Patrick CALVAS Patrick Calvas, Service de Génétique médicale, Hôpital de Purpan
  • Sophie JULIA Sophie Julia, Inserm UMR 1027, Université Toulouse III Paul Sabatier
  • Christelle GARNIER Christelle Garnier, Service de Génétique Médicale, Hôpital de Purpan
  • Anne CAMBON THOMSEN Anne Cambon-Thomsen, Inserm UMR 1027, Université Toulouse III Paul Sabatier
  • Maria Teresa MUNOZ SASTRE Maria Teresa Munoz Sastre, Université Toulouse II Jean Jaurès

Keywords:

high-throughput sequencing genetic test, acceptability, unsolicited genetic finding

Abstract

Objective: New genome sequencing techniques allow new approaches in medical genetics, in particular by facilitating the diagnosis of genetic diseases. However, their use also leads to unsolicited genetic findings being uncovered. This type of discovery raises ethical, legal and psychological considerations. The objective of this psychological research was to study the different positions of patients, health professionals and general public regarding the acceptability of the announcement of unsolicited findings revealed during a high-throughput sequencing genetic test.
Method: the first exploratory study aimed, through non-directive research interviews conducted with 13 patients of a medical genetics service, to understand the psychological repercussions linked to the announcement of a result of a targeted genetic test and to know the patients’ desires regarding the announcement of unsolicited findings if the test had been a high-throughput genetic test. The second study, using a quantitative methodology, aimed to identify the judgment policies of 144 patients, 94 healthcare professionals and 211 people from the general public concerning the acceptability of this type of disclosure.
Results: The cluster analyses highlighted six judgment policies as to whether or not to disclose the discovery of unsolicited anomalies: “Tell everything”, “Tell even in part”, “Tell everything unless desperate”, “Undecided”, “Do not tell” and “Do not tell if no prevention”. The participants positioned themselves differently, in particular according to the patient’s consent.
Conclusion: This research shows the variability of positioning and the importance of consent in the acceptability of the disclosure of unsolicited findings. However, one of the limitations of the study lies in the fact that in medical clinic, acceptability and acceptance may vary over time. A longitudinal study would undoubtedly afford a better understanding of the psychological progress of patients in this type of care pathway..

Published

2023-07-26

How to Cite

Myriam GUEDJ, Marion ROSIER, Patrick CALVAS, Sophie JULIA, Christelle GARNIER, Anne CAMBON THOMSEN, & Maria Teresa MUNOZ SASTRE. (2023). DISCLOSING OR NOT THE UNSOLICITED FINDINGS DURING A HIGH-THROUGHPUT SEQUENCING GENETIC TEST? AN EXAMPLE OF RESEARCH TO UNDERSTAND THE WEIGHT GIVEN TO CONSENT IN DECISION-MAKING. Journal International De bioéthique Et d’éthique Des Sciences, 34(2), 121. Retrieved from https://journaleska.com/index.php/jidb/article/view/9024

Issue

Section

Articles